These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 316419

  • 1. Relationships among differentiated T-cell subpopulations. V. T-cell dependent mechanism of xenograft rejection and its radioresistant nature.
    Terasaka R, Nomoto K, Himeno K.
    Immunology; 1979 Dec; 38(4):773-9. PubMed ID: 316419
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of xenograft rejection. I. Augmented cytotoxicity of peritoneal T cells after intraperitoneal injection of booster antigen and/or proteose peptone.
    Terasaka R, Himeno K, Shiraishi M, Nomoto K.
    Jpn J Exp Med; 1981 Apr; 51(2):75-80. PubMed ID: 6974262
    [Abstract] [Full Text] [Related]

  • 3. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A, Kuribayashi K, Sakaguchi S, Masuda T, Yamashita J, Handa H, Nakayama E.
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection.
    Nomoto K, Terasaka R, Himeno K, Shiraishi M.
    Jpn J Exp Med; 1981 Apr; 51(2):81-7. PubMed ID: 6974263
    [Abstract] [Full Text] [Related]

  • 5. Anti B and T cell activity of antiserum to spleen cells of athymic (nu/nu) mice: evidence for surface antigenic differences between functionally distinct subclasses of T and B lymphocytes.
    Kisielow P, Shiku H.
    Arch Immunol Ther Exp (Warsz); 1976 Apr; 24(5):671-88. PubMed ID: 63275
    [Abstract] [Full Text] [Related]

  • 6. Relationships among differentiated T-cell subpopulations. IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature.
    Terasaka R, Nomoto K, Himeno K, Takeya T.
    Immunology; 1979 Apr; 36(4):699-705. PubMed ID: 312268
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 8. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL, Shih CY, Lefever AV, Tempelis LD, Andreani M, Bortin MM.
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [Abstract] [Full Text] [Related]

  • 9. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.
    Doherty PC, Zinkernagel RM.
    Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923
    [Abstract] [Full Text] [Related]

  • 10. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M.
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [Abstract] [Full Text] [Related]

  • 11. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 12. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M.
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F, Nomoto K, Taniguchi K, Kubo C.
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [Abstract] [Full Text] [Related]

  • 14. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 15. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B, Jones TC.
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [Abstract] [Full Text] [Related]

  • 16. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 17. Direct cytotoxicity against chicken erythrocytes in mice. I. Fundamental nature of T cell-mediated cytotoxicity.
    Kubo C, Nomoto K, Sato M, Takeya K.
    Immunology; 1977 Dec; 33(6):895-905. PubMed ID: 304039
    [Abstract] [Full Text] [Related]

  • 18. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 19. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G, Rosen D.
    J Immunol; 1988 Sep 01; 141(5):1429-36. PubMed ID: 3261748
    [Abstract] [Full Text] [Related]

  • 20. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH, Gurish MF, Daynes RA.
    Immunology; 1982 Sep 01; 47(1):49-59. PubMed ID: 6981587
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.